TITLE

Antworten zu den Fragen zu Probiotika bei gastrointestinalen Erkrankungen aus PRAXIS Nr. 17

PUB. DATE
September 2012
SOURCE
Praxis (16618157);9/19/2012, Vol. 101 Issue 18, p1213
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
79788771

 

Related Articles

  • EDITOR'S QUIZ: GI SNAPSHOT: Late complications of an ileal pouch. Spiller, Robin; Munikrishnan, V.; Ryley, N.; Teague, R.; Pullan, R. D. // Gut;Nov2005, Vol. 54 Issue 11, p1514 

    Presents a quiz related to the diagnosis of ulcerative colitis.

  • ask our experts.  // Good Health (Australia Edition);Nov2011, p184 

    The article presents questions and answers related to health including one on Ulcerative colitis and Crohn's disease, one on drug treatment for melanoma, and one on whether being depressed can increase the risk for stroke.

  • Corrigendum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Anderson, Carl A.; Boucher, Gabrielle; Lees, Charlie W.; Franke, Andre; D'Amato, Mauro; Taylor, Kent D.; Lee, James C.; Goyette, Philippe; Imielinski, Marcin; Latiano, Anna; Lagacé, Caroline; Scott, Regan; Amininejad, Leila; Bumpstead, Suzannah; Baidoo, Leonard; Baldassano, Robert N.; Barclay, Murray; Bayless, Theodore M; Brand, Stephan; Büning, Carsten // Nature Genetics;Sep2011, Vol. 43 Issue 9, p919 

    A correction to the article "Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47" that was published in the August 11, 2011 issue.

  • WHAT ARE PROBIOTICS?  // Southern Living;Jan2009, Vol. 44 Issue 1, p110 

    The article offers information on probiotics. Probiotics are live bacteria that are beneficial to health. These bacteria naturally live in people's digestive tracts to fight off pathogens, but they need to be replenished from time to time. Yogurt contains two probiotic starter cultures, namely...

  • ANTIOXIDANT ACTIVITY OF THE PROBIOTIC CONSORTIUM IN VITRO. Kushugulova, A.; Saduakhasova, S.; Kozhakhmetov, S.; Shakhabayeva, G.; Tynybayeva, I.; Nurgozhin, T.; Marotta, F.; Zhumadilov, Zh. // International Journal of Probiotics & Prebiotics;Feb-May2014, Vol. 9 Issue 1/2, p55 

    The antioxidant and antigenotoxic properties of the probiotic consortium, including the strains Streptococcus thermophilus, Lactococcus lactis, Lactobacillus plantarum, Lactobacillus fermentum, Lactobacillus acidophilus, Bifidobacterium longum, Bifidobacterium bifidum, were investigated....

  • Serological markers of inflammatory bowel disease. Kuna, Andrea Tešija // Biochemia Medica;2013, Vol. 23 Issue 1, p28 

    Inflammatory bowel disease (IBD) is a heterogeneous group of chronic inflammatory disorders of the gastrointestinal tract with two main distinguishable entities, Crohn's disease (CO) and ulcerative colitis (UC). IBD-undassified (IBD-U) is a diagnosis that covers the "grey" zone of diagnostic...

  • Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy. Agrawal, Amit; Sharma, Barjesh Chander; Sharma, Praveen; Sarin, Shiv Kumar // American Journal of Gastroenterology;Jul2012, Vol. 107 Issue 7, p1043 

    OBJECTIVES:Lactulose is effective in secondary prophylaxis of hepatic encephalopathy (HE). Probiotics improves minimal hepatic encephalopathy (MHE), which predisposes to HE. No study has been conducted on the secondary prophylaxis of HE using probiotics. Our objective was to study the effects of...

  • A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. Ritchie, Marina L.; Romanuk, Tamara N. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: Meta-analyses on the effects of probiotics on specific gastrointestinal diseases have generally shown positive effects on disease prevention and treatment; however, the relative efficacy of probiotic use for treatment and prevention across different gastrointestinal diseases, with...

  • Treatment algorithm for stress ulcer reduces costs in Canada.  // PharmacoEconomics & Outcomes News;6/18/2005, Issue 480, p14 

    Discusses research being done on the cost benefits of a treatment algorithm introduced by pharmacists for stress ulcer prophylaxis in Canada. Reference to a study by C. J. Coursol and S. E. Sanzari published in the May 2005 issue of the periodical "Annals of Pharmacotherapy"; Effect of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics